Ascletis Pharma Inc. (2VJ)
Market Closed
11 Aug, 20:00
XFRA 
€
1. 16
+0.01
+0.8696%
€
1.77B Market Cap
- P/E Ratio
- Div Yield
1,382 Volume
- Eps
€ 1.15
Previous Close Want to track 2VJ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ascletis Pharma Inc. (2VJ) Statistics
Valuation metrics
Market Cap 1.77B
Enterprise value -40.7M
Trailing P/E (ttm) -4.54
Forward P/E -
PEG ratio -
Price/Sales (ttm) 827.41
Price/Book (mrq) 6.45
Enterprise Value/Revenue -158.63
Enterprise Value/EBITDA 0.68
Overview
Shares outstanding 986.09M
Float 218.65M
Shares short -
% Held by insiders 0.65%
% Held by institutions 0.12%
Average volume (10 days) 235
Average volume (90 days) 102
Price summary
52-Week low 0.91
52-Week high 2.06
Beta 0.47
50-Day moving average 1.77
200-Day moving average 1.48
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 30 Jun 2018
Profitability
Profit margin 0.26%
Operating margin -310.64%
Operational effectiveness
Return on assets -0.14%
Return on equity -0.18%
Income Statement
Revenue (ttm) 256.56K
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -0.26%
Gross profit (ttm) 66.67K
EBITDA -59.67M
Net income to common (ttm) -45.53M
Diluted EPS (ttm) -0.05
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 240.87M
Total cash per share (mrq) 1.92
Total debt (mrq) 652.54K
Total Debt/Equity (mrq) 0.27
Current ratio (mrq) 15.05%
Book value per share (mrq) 0.25
Cash Flow
Cash flow statement -52.73M
Levered free cash flow (LFCF) -37.74M
